NL
N1 Life develops a proprietary peptide-based delivery platform, Absotride™, designed to enhance the penetration and targeted efficacy of active ingredients in topical applications. This technology overcomes biological barriers to optimize how actives reach their intended depth within the skin. The company provides solutions for improving the performance of skincare, dermatology, and hair/scalp care formulations.
Milpitas, United States
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This biotech company has developed a tissue-selective drug delivery platform that enhances the localization of therapeutic agents, thereby increasing treatment efficacy. By minimizing off-target effects, the platform reduces systemic toxicity in patients, improving overall safety profiles of therapies.